This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Leland Stanford Junior University. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Ole Audun Werner Haabeth
Introduction
Ole Audun Werner Haabeth is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of nucleic acid delivery through his innovative patents. With a total of two patents to his name, Haabeth is recognized for his advancements in biochemistry and molecular biology.
Latest Patents
Haabeth's latest patents include "Hybrid immolative cell-penetrating complexes for nucleic acid delivery." This patent provides complexes, compositions, and methods for delivering nucleic acids into cells in vivo. The innovations facilitate the complexation, protection, delivery, and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs both in vitro and in vivo. Another significant patent is "Immolative cell-penetrating complexes for nucleic acid delivery to the lung." This invention includes cationic amphipathic polymers, complexes, and compositions for delivering therapeutic, diagnostic, and imaging agents, including nucleic acids, into cells. These methods enhance the targeted release of agents to specific cell types and tissues.
Career Highlights
Haabeth is affiliated with Leland Stanford Junior University, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in medicine and biotechnology.
Collaborations
Some of his notable coworkers include Tim R Blake and Robert M Waymouth, who have collaborated with him on various projects and research initiatives.
Conclusion
Ole Audun Werner Haabeth is a prominent inventor whose work in nucleic acid delivery has the potential to revolutionize therapeutic approaches in medicine. His patents reflect a commitment to advancing scientific knowledge and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
